Breaks Categories: News

TuesdayMar 10, 2020 11:35 am

NetworkNewsBreaks – Arcus Biosciences, Inc. (NYSE: RCUS) Featured in Mizuho Securities Research Report

Arcus Biosciences, Inc. (NYSE: RCUS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We like shares of RCUS based on the combinatorial approach to development of its immuno-oncology (I/O)-focused pipeline. The 4Q19 EPS update reaffirmed the development strategy for 2020, including catalysts for initial data for AB928+FOLFOX in mCRC (AACR) and preliminary randomization data from AB154 (anti-TIGIT) in 1st-line NSCLC. The shares have rallied this year based on interest in AB154, in our view, which is understandable following the external validation of the program via competitor advancement into Phase III, as…

Continue Reading

TuesdayMar 10, 2020 11:26 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation (DCF and EV/Sales) to derive our $54 PT. Our assumptions include: Rhopressa: U.S. peak-sales of $162 mil in 2025. Rocklatan: U.S. peak-sales of $331 mil in 2025. DCF Assumptions: Terminal value of 5x 2028 FCF and a 11% discount rate to derive a$49 PT. EV/Sales Assumptions: 7x multiple of 2028 sales, discounted at 11% to derive a $58 PT. In our bull case scenario, we assume greater than anticipated market share of…

Continue Reading

TuesdayMar 10, 2020 11:18 am

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “In our bull case scenario, we assume greater than expected uptake of the Xeris glucagon rescue pen. We project peak market share reaching ~60% for total U.S. peak sales of$494mn in 2029. In addition, we also apply a higher multiple of 5x in our EV/Sales methodology to account for higher growth. This translates into a $25 PT” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals, Inc. Xeris is a specialty pharmaceutical company delivering innovative…

Continue Reading

TuesdayMar 10, 2020 9:52 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly subscription rate of $19.95 now includes an option of three (3) premium visits per month as well as free prescription delivery service through its subsidiaries. A virtual healthcare subsidiary, Bonum Health provides telehealth services and prescription ordering via teleconferences that are routinely conducted using smart devices. The company provides a HIPPA compliant, dynamic way for patients to access board-certified physicians from the comfort of their…

Continue Reading

MondayMar 09, 2020 3:27 pm

NetworkNewsBreaks – INEO Tech Corp. (TSX.V: INEO) Retains Angad Capital Inc. for Advisory Services

INEO Tech (TSX.V: INEO), the developer of The Welcoming System for retailers, recently announced that it has engaged Angad Capital Inc. to deliver investor relations services, corporate strategy and capital markets advisory, subject to approval by the TSX Venture Exchange. In relation to the engagement, Angad was awarded a consulting agreement for an initial term of one year beginning March 1, 2020, for a monthly fee of C$10,000. INEO also granted Angad options to purchase 500,000 common shares in the capital of the company at a price of $0.26 each, in accordance with the company’s Stock Option Plan. The options…

Continue Reading

MondayMar 09, 2020 12:18 pm

NetworkNewsBreaks – Global Water Resources, Inc. (NASDAQ: GWRS) Featured in ROTH Equity Research Report

Global Water Resources, Inc. (NASDAQ: GWRS) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “GWRS continues to be positioned for growth over the next several years. Permit activity supports 4%-5% organic connection growth. In addition, the recent equity offering reloads the balance sheet for continued infrastructure investment (rates) and opportunities for acquisitions. Finally, we anticipate a rate case filing by June 2020, which should add new rates to the income state potentially impacting 2H 21 and 2022. We believe GWRS is the fastest growing water utility in the US with the…

Continue Reading

MondayMar 09, 2020 12:12 pm

NetworkNewsBreaks – Himax Technologies Inc. (NASDAQ: HIMX) Featured in ROTH Equity Research Report

Himax Technologies Inc. (NASDAQ: HIMX) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We hosted a series of investor meetings with HIMX management. We believe HIMX is benefitting across multiple segments from favorable market trends and has already adjusted guidance for current macro uncertainty. We expect share gain related benefit across both large and small display driver along with incremental non-driver 3D sensing opportunities across multiple platforms. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Himax Technologies Inc. Himax Technologies, Inc. is a fabless…

Continue Reading

MondayMar 09, 2020 12:05 pm

NetworkNewsBreaks – Smith Micro Software, Inc. (NASDAQ: SMSI) Featured in ROTH Equity Research Report

Smith Micro Software, Inc. (NASDAQ: SMSI) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “Smith Micro reported another beat and raise (6th consecutive quarter) driven by continued strength in SafPath (~600k subs and ~6% penetration). More importantly, the company provided more insight into the recently completed Circle Media Labs acquisition which dramatically upgrades SMSI’s parental controls, accelerates product development and adds T-Mobile to its customer ranks. With the Sprint/T-Mobile acquisition de-risked SMSI remains a focus name for 2020. We maintain our Buy and raise our PT to $11.25.” To request access…

Continue Reading

MondayMar 09, 2020 11:59 am

NetworkNewsBreaks – SilverCrest Metals Inc. (NYSE American: SILV) Featured in ROTH Equity Research Report

SilverCrest Metals Inc. (NYSE American: SILV) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “On March 5, 2020, SilverCrest Metals announced metallurgical test results from its high-grade Las Chispas project. Importantly, the study outlined an increase in both gold and silver recoveries compared with the existing PEA, which we believe sets the stage for enhanced economics in the upcoming Feasibility Study. As such, we are reiterating a Buy rating increasing our price target to $10.50 from $10.00 per share.” To request access to the full report, visit http://nnw.fm/DXCr3 About SilverCrest Metals…

Continue Reading

MondayMar 09, 2020 11:53 am

NetworkNewsBreaks – Enphase Energy, Inc. (NASDAQ: ENPH) Featured in ROTH Equity Research Report

Enphase Energy, Inc. (NASDAQ: ENPH) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “ENPH is taking advantage of an attractive convertible debt market (due to low interest rates and high volatility) to issue convertible debt at attractive terms. This gives ENPH a war chest with a backdrop of COVID-19 and overall market uncertainty, while also giving ENPH greater flexibility around potential future strategic transactions. Reiterate Buy and 2020 Top Pick, PT to street-high $70 from $55.” To request access to the full report, visit http://nnw.fm/DXCr3 About Enphase Energy, Inc. Enphase is…

Continue Reading